--- title: "GLP-1 Cost in India" description: "How much does GLP-1 cost per month in India? Educational INR ranges by drug class for semaglutide, tirzepatide, and more." canonical: "https://www.kesho.health/keywords/glp-1-cost-india" markdown_url: "https://www.kesho.health/md/keywords/glp-1-cost-india" language: "en-IN" primary_keyword: "GLP-1 cost India" --- # GLP-1 cost in India — what patients actually pay > **Short answer:** GLP-1 receptor agonists in India typically cost ₹6,000–₹25,000 per month out-of-pocket depending on drug class, dose, city tier, and generic vs innovator sourcing. Insurance rarely covers obesity indication. Budget for long-term therapy. **Canonical HTML:** https://www.kesho.health/keywords/glp-1-cost-india **Markdown:** https://www.kesho.health/md/keywords/glp-1-cost-india ## Before you buy **Check chemist quote** — Compare a pharmacy quote against typical CDSCO-approved GLP-1 ranges — spot grey-market pricing before you pay. [Check chemist quote](https://www.kesho.health/chemist-quote-check) **Monthly budget worksheet** — Plan medicine, labs, consultations, and travel costs for 12–24 months of GLP-1 therapy in India. [Monthly budget worksheet](https://www.kesho.health/glp-1-budget-worksheet) ## Why costs vary so much in India Monthly GLP-1 expenses depend on the molecule (semaglutide vs tirzepatide), whether you use generic or innovator products, your titration dose, and your city tier. Metro cities like Mumbai and Delhi run 10% higher than tier-2 centres. Oral semaglutide is priced similarly to injectable forms in many markets. ## Drug-class cost ranges (2026 estimates) Generic injectable semaglutide: approximately ₹6,000–₹14,000/month. Tirzepatide (dual GIP/GLP-1): ₹15,000–₹25,000/month. Liraglutide (daily injection): ₹8,000–₹12,000/month. These are educational ranges — verify with your pharmacy. ## Hidden costs to plan for Beyond the medicine itself, budget for consultation fees (₹800–₹2,500 per visit), lab tests (HbA1c, lipids, kidney function every 3–6 months), dietitian sessions, and cold-chain storage if you travel frequently. ## Insurance and corporate coverage in India Most Indian health insurance policies exclude outpatient obesity pharmacotherapy. Corporate wellness plans in metros sometimes subsidise HbA1c labs or diabetes-labelled GLP-1 with prior authorisation—rare for weight-only indications. CGHS and state schemes generally do not cover monthly GLP-1 pens. Ask your HR benefits team for written formulary confirmation before assuming coverage. ## Generic semaglutide and 2026 pricing trends Post-patent generic injectable semaglutide is the largest cost lever for Indian households. CDSCO-approved generics from licensed manufacturers often sit ₹2,000–₹5,000 below innovator pricing per month at maintenance dose. Tirzepatide remains premium-priced. Compare itemised pharmacy quotes including GST—not influencer discount codes from unlicensed sellers. ## Metro vs tier-2 cost differences Mumbai and Delhi retail pharmacies typically quote 8–12% above tier-2 cities for the same CDSCO-approved molecule. Tier-2 patients may save by purchasing during quarterly metro specialist visits if local cold-chain stock is unreliable—factor travel cost against savings. Apollo, MedPlus, and hospital dispensaries within the same city can differ by ₹500–₹1,500 per pen. ## How to verify quotes legally Request written quotes with product name, strength, pen count, batch number, and GST. Reject sellers offering prescription-free delivery or prices far below licensed pharmacy norms—CDSCO has issued repeated advisories against grey-market GLP-1. Schedule H medicines require a valid prescription from an NMC-registered physician. See our verification guide before paying online. ## Monthly budgeting worksheet for Indian families List maintenance-dose pen cost, quarterly consultation fees, HbA1c and lipid panels twice yearly, dietitian visits if recommended, insulated travel pouch, and sharps disposal. Multiply the medicine line by twenty-four for a two-year horizon. Share the worksheet with your endocrinologist at initiation—affordability conversations prevent mid-year discontinuation when refills surprise household budgets. Include GST in every quote and confirm pen count covers a full calendar month at your prescribed dose. ## Titration months cost more than maintenance First three to six months often use lower doses while titrating, which can reduce pen cost temporarily—but consultation and lab frequency is highest during this phase. Do not extrapolate titration-month spending as long-term average. Doctors may pause escalation if nausea persists, extending lower-dose months. Budget for at least six months at escalating spend before maintenance plateau. ## City-specific cost pages on Kesho Mumbai, Delhi, Bangalore, Hyderabad, Chennai, Kolkata, and Pune each have dedicated cost context pages with local pharmacy patterns and storage tips. Tier-2 patients comparing metro travel versus local stock-outs should read city guides alongside this overview. National averages hide ten-to-fifteen percent metro premiums and generic availability differences that affect your out-of-pocket total. ## When stopping GLP-1 wastes prior spending Abrupt unsupervised discontinuation often reverses glycaemic and weight progress achieved over months—invested rupees and clinical gains are lost together. If cost becomes unaffordable, discuss generic switches, slower titration, or structured tapering with your physician before skipping doses. False economy from grey-market pens or sub-therapeutic dosing wastes money while preserving side-effect risk without benefit. ## Evidence sources for Indian cost data Kesho cites CDSCO approval lists, RSSDI prescribing context, and pharmacy quote surveys across metros—not manufacturer marketing materials. Prices change when new generics launch; verify current quotes at refill. Our complete cost guide links PubMed and ICMR references for clinical context alongside rupee estimates updated for 2026. Download the markdown alternate for AI research tools. ## Using Kesho before your pharmacy visit Print or save this page and our city cost guide before collecting quotes today. Ask each pharmacist the same four questions: CDSCO approval status, generic versus innovator molecule, GST-inclusive total, and cold-chain policy. Consistent questions reveal real price differences instead of promotional distractions. Note batch numbers on every invoice for your personal cost log. Share quotes with your doctor if affordability affects dose adherence. Updated for 2026 Indian market conditions across all major metros. ## Quick questions ### Is GLP-1 Cost in India information on Kesho medical advice? No. Kesho provides drug-class education only. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised treatment decisions. ### Where is the full guide? See our complete medically reviewed guide linked on this page for in-depth coverage with references and India-specific context. ### What is the short answer on glp-1 cost in india? GLP-1 receptor agonists in India typically cost ₹6,000–₹25,000 per month out-of-pocket depending on drug class, dose, city tier, and generic vs innovator sourcing. Insurance rarely covers obesity indication. Budget for long-term therapy. ## Complete guide [glp-1-cost-india-2026](https://www.kesho.health/blog/glp-1-cost-india-2026) · [MD](https://www.kesho.health/md/blog/glp-1-cost-india-2026) ## Related guides - [Cheapest GLP-1 Options in India: A Drug-Class Cost Guide](https://www.kesho.health/blog/cheapest-glp-1-india-drug-class) - [GLP-1 Cost in Mumbai, Delhi & Bengaluru: City Price Guide](https://www.kesho.health/blog/glp-1-cost-mumbai-delhi-bangalore) - [GLP-1 Insurance Coverage in India: What Patients Can Expect](https://www.kesho.health/blog/glp-1-insurance-india) --- *Drug-class education only — not medical advice. [Kesho](https://www.kesho.health)*